hesperidin has been researched along with clarithromycin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Aguilar, JA; Cassani, J; Colbourne, AA; Morris, GA; Nilsson, M | 1 |
| Abdalla, M; Arif, M; Chi, Z; Khan, S; Liu, C; Shabana, S; Sharaf, M | 1 |
3 other study(ies) available for hesperidin and clarithromycin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Decoupling two-dimensional NMR spectroscopy in both dimensions: pure shift NOESY and COSY.
Topics: Clarithromycin; Flavanones; Hesperidin; Magnetic Resonance Spectroscopy; Molecular Structure | 2012 |
Co-delivery of hesperidin and clarithromycin in a nanostructured lipid carrier for the eradication of Helicobacter pylori in vitro.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Clarithromycin; Dose-Response Relationship, Drug; Drug Carriers; Drug Delivery Systems; Helicobacter pylori; Hesperidin; Lipids; Microbial Sensitivity Tests; Molecular Structure; Nanoparticles; Structure-Activity Relationship | 2021 |